Baseline characteristics of study participants, stratified by the development of progressive chronic kidney disease (CKD).

Baseline was defined at randomization into the parent trial (SMART or ESPRIT).Categorical variables are presented as N (%) and continuous variables presented as median (interquartile range).1Data on HIV RNA and Hepatitis B surface antigen were available for 3435 participants (99.8%).2Data on Hepatitis C antibody status were available for 3436 participants (99.8%).3Among 473 participants with positive Hepatitis C antibody, RNA viral load was available for 471 (99.6%) and genotype was available for 353 (74.6%).eGFR, estimated GFR calculated using the CKD-EPI formula; BMI, body mass index.